Literature DB >> 6483587

Calcium-dependent atrial slow action potentials generated with phosphatidic acid or phospholipase D.

M T Knabb, R Rubio, R M Berne.   

Abstract

Phosphatidic acid (PA) formed following phosphatidylinositol hydrolysis has been proposed as a necessary step in receptor-mediated Ca2+ flux. This study demonstrates that PA generates Ca2+-dependent slow action potentials (APs) in rat atrium partially depolarized with 22 mM K+. The slow response was not due to release of endogenous catecholamines or prostaglandin formation since propranolol and indomethacin failed to attenuate the PA-induced slow AP in normal and reserpinized rats. PA-induced slow APs demonstrated Ca2+-dependence such that increasing [Ca2+]o from 0.5 to 5.0 mM caused the amplitude of the slow AP to rise linearly with the logarithm of [Ca2+]o. Phospholipase D (PLD) but not phospholipase C, was able to induce a slow AP, possibly through PA formation. Adenosine attenuated the PA and PLD-induced slow response and aminophylline reversed these effects. The observation that PA and PLD generate Ca2+-dependent slow APs in depolarized rat atrium supports a role for PA mediating Ca2+ influx.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6483587     DOI: 10.1007/bf00584352

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  11 in total

Review 1.  Inositol phospholipids and cell surface receptor function.

Authors:  R H Michell
Journal:  Biochim Biophys Acta       Date:  1975-03-25

2.  On the sarcolemmal site of action of cardiac glycosides.

Authors:  H Lüllmann; T Peters
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1976

Review 3.  Phosphatidylinositol hydrolysis: a multifunctional transducing mechanism.

Authors:  M J Berridge
Journal:  Mol Cell Endocrinol       Date:  1981-11       Impact factor: 4.102

4.  Blockade of Ca2+ dependent rat atrial slow action potentials by adenosine and lanthanum.

Authors:  L Belardinelli; R Rubio; R M Berne
Journal:  Pflugers Arch       Date:  1979-05-15       Impact factor: 3.657

5.  Proposed mechanism of cholinergic action in smooth muscle.

Authors:  D M Salmon; T W Honeyman
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

6.  Potentiation of slow action potentials with theophylline or "micro" adenosine deaminase.

Authors:  M T Knabb; R Rubio; R M Berne
Journal:  Am J Physiol       Date:  1983-03

7.  Uncoupling cation effects on cardiac contractility and sarcolemmal Ca2+ binding.

Authors:  D M Bers; G A Langer
Journal:  Am J Physiol       Date:  1979-09

8.  Phosphatidate and oxidized fatty acids are calcium ionophores. Studies employing arsenazo III in liposomes.

Authors:  C Serhan; P Anderson; E Goodman; P Dunham; G Weissmann
Journal:  J Biol Chem       Date:  1981-03-25       Impact factor: 5.157

9.  Correlation of alterations in cation exchange and sarcolemmal ultrastructure produced by neuraminidase and phospholipases in cardiac cell tissue culture.

Authors:  G A Langer; J S Frank; K D Philipson
Journal:  Circ Res       Date:  1981-12       Impact factor: 17.367

10.  Phosphatidate as a molecular link between depolarization and neurotransmitter release in the brain.

Authors:  R A Harris; J Schmidt; B A Hitzemann; R J Hitzemann
Journal:  Science       Date:  1981-06-12       Impact factor: 47.728

View more
  3 in total

1.  Kinetics of myocardial phospholipase D.

Authors:  J Dai; S Y Liu; V Panagia
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Post-ischemic release of nucleosides and oxypurines in isolated rat hearts. Possible involvement of ventricular fibrillation.

Authors:  W Bernauer
Journal:  Basic Res Cardiol       Date:  1991 Jan-Feb       Impact factor: 17.165

3.  Effect of exogenous adenosine deaminase on arrhythmias and the release of adenine nucleotide catabolites in isolated rat hearts with coronary occlusion and reperfusion.

Authors:  W Bernauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.